LeafNLP Demos
Back to explore

Report #2883090

Received Jan 24, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MO
Recovered
Unknown
Vaccinated
Jan 19, 2026
Onset
Jan 19, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HIBVHIB (HIBERIX)GLAXOSMITHKLINE BIOLOGICALSUNKKA532—

Symptoms (1)

Product preparation issue

Symptom narrative

MI Hiberix Administration of only the diluent portion; MI Hiberix Administration of only the diluent portion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 4-month-old female patient who received Hib (Hiberix) (batch number KA532, expiry date 19-OCT-2026) for prophylaxis. On 19-JAN-2026, the patient received Hiberix. On 19-JAN-2026, an unknown time after receiving Hiberix, the patient experienced inappropriate dose of vaccine administered (Verbatim: MI Hiberix Administration of only the diluent portion) and inappropriate preparation of medication (Verbatim: MI Hiberix Administration of only the diluent portion). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 20-JAN-2026 A nurse mentioned that an employee administered only the liquid portion of Hiberix to a patient. The nurse wants to know if it was possible to use a different saline solution to reconstitute the Hiberix powder in order to not waste the vaccine. The lot number provided corresponds to the vial containing the lyophilized component.